Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
The FDA is beginning rulemaking to close the “adequate provision” loophole
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
AINU is set to accelerate its expansion footprint, enhance operational capabilities
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Subscribe To Our Newsletter & Stay Updated
